AGP Executive Report
Last update: 10 hours agoSpace & Health Research: Nevis and partners including the University of Zurich and the Centre for Space and Aviation Switzerland and Liechtenstein launched the first Caribbean space life sciences experiment (May 31) to study how microgravity and hypergravity affect human immune cells and gene activity—aimed at improving health knowledge for long-duration missions. Pet Health Tech in the Region: Fi expanded its AI-powered GPS pet wearables and connectivity network to 38 countries, adding several European markets and extending coverage to Switzerland, Norway, Liechtenstein, Iceland and Turkey—positioning the devices as tools for tracking health-related behavior trends. Cancer Care Update (EU): The European Commission authorized expanded use of Bristol Myers Squibb’s Opdivo (nivolumab) plus AVD for newly diagnosed advanced classical Hodgkin lymphoma in adults and adolescents (12+), marking a first immunotherapy-based regimen in the EU for this setting. Transplant Outcomes: Hansa Biopharma reported strong one-year results for Idefrix (imlifidase) after HLA-incompatible kidney transplants, with 90% graft failure-free survival in a European post-authorization study. Heat & Safety: A deadly spring heat wave across Europe shattered temperature records and has already been linked to multiple deaths, raising urgent public-safety concerns during extreme temperatures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
